These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6105247)

  • 1. Removal of hepatitis-B-virus infectivity from factor-IX complex by hepatitis-B immune-globulin. Experiments in chimpanzees.
    Tabor E; Aronson DL; Gerety RJ
    Lancet; 1980 Jul; 2(8185):68-70. PubMed ID: 6105247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sterilisation of hepatitis and HTLV-III viruses by exposure to tri(n-butyl)phosphate and sodium cholate.
    Prince AM; Horowitz B; Brotman B
    Lancet; 1986 Mar; 1(8483):706-10. PubMed ID: 2870224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addition of hepatitis-B immunoglobulin to clotting factor.
    Scaroni C; Cancellieri V; Carnelli V; Moroni GA; Angeli M
    Lancet; 1980 Sep; 2(8193):537-8. PubMed ID: 6105587
    [No Abstract]   [Full Text] [Related]  

  • 4. Addition of hepatitis-B immunoglobulin to clotting factors.
    Smit Sibinga CT; Das PC; Nieweg HO
    Lancet; 1980 Sep; 2(8193):537. PubMed ID: 6105586
    [No Abstract]   [Full Text] [Related]  

  • 5. Chromatographic removal of hepatitis B virus from a factor IX concentrate. Experimental studies in chimpanzees.
    Iwarson S; Einarsson M; Smallwood L; Snoy P; Gerety RJ
    Transfusion; 1987; 27(2):171-3. PubMed ID: 3824476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Removal of hepatitis B virus infectivity from human gamma-globulin prepared by ion-exchange chromatography.
    Zolton RP; Padvelskis JV; Kaplan PM
    Vox Sang; 1985; 49(6):381-9. PubMed ID: 2418590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the effect of betapropiolactone/ultraviolet irradiation (BPL/UV) treatment of source plasma on hepatitis transmission by factor IX complex in chimpanzees.
    Prince AM; Stephan W; Brotman B; van den Ende MC
    Thromb Haemost; 1980 Dec; 44(3):138-42. PubMed ID: 7466740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody to hepatitis-B-virus core in man.
    Hoofnagle JH; Gerety RJ; Barker LF
    Lancet; 1973 Oct; 2(7834):869-73. PubMed ID: 4126916
    [No Abstract]   [Full Text] [Related]  

  • 9. Titration of the infectivity of hepatitis D virus in chimpanzees.
    Ponzetto A; Hoyer BH; Popper H; Engle R; Purcell RH; Gerin JL
    J Infect Dis; 1987 Jan; 155(1):72-8. PubMed ID: 3794405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutralization of hepatitis B virus (HBV) by human monoclonal antibody against HBV surface antigen (HBsAg) in chimpanzees.
    Kim SH; Shin YW; Hong KW; Chang KH; Ryoo KH; Paik SH; Kim JM; Brotman B; Pfahler W; Prince AM
    Antiviral Res; 2008 Sep; 79(3):188-91. PubMed ID: 18479762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contributions to the optimal use of human blood. IX. Elimination of hepatitis B transmission by (potentially) infectious plasma derivatives.
    Brummelhuis HG; Over J; Duivis-Vorst CC; Wilson-de Stürler LA; Ates G; Hoek PJ; Reerink-Brongers EE
    Vox Sang; 1983; 45(3):205-16. PubMed ID: 6624009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure to detect infectious hepatitis B virus using high dose safety test for hepatitis B vaccine.
    Tabor E; Barker LF; Gerety RJ
    J Med Virol; 1981; 6(4):279-84. PubMed ID: 7241095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B e antigen and infectivity of hepatitis B virus.
    Shikata T; Karasawa T; Abe K; Uzawa T; Suzuki H; Oda T; Imai M; Mayumi M; Moritsugu Y
    J Infect Dis; 1977 Oct; 136(4):571-6. PubMed ID: 908854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-A/non-B hepatitis in experimentally infected chimpanzees: cross-challenge and electron microscopic studies.
    Bradley DW; Maynard JE; Cook EH; Ebert JW; Gravelle CR; Tsiquaye KN; Kessler H; Zuckerman AJ; Miller MF; Ling C; Overby LR
    J Med Virol; 1980; 6(3):185-201. PubMed ID: 6785393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B immune globulin.
    N Engl J Med; 1978 Nov; 299(22):1254. PubMed ID: 714088
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatitis B virus infection in chimpanzees: titration of subtypes.
    Barker LF; Maynard JE; Purcell RH; Hoofnagle JH; Berquist KR; London WT; Gerety RJ; Krushak DH
    J Infect Dis; 1975 Oct; 132(4):451-8. PubMed ID: 1185011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccine against human hepatitis B.
    Buynak EB; Roehm RR; Tytell AA; Bertland AU; Lampson GP; Hilleman MR
    JAMA; 1976 Jun; 235(26):2832-4. PubMed ID: 819667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and chimpanzee testing of a vaccine against human hepatitis B.
    Buynak EB; Roehm RR; Tytell AA; Bertland AU; Lampson GP; Hilleman MR
    Proc Soc Exp Biol Med; 1976 Apr; 151(4):694-700. PubMed ID: 817293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of 10(15) chimpanzee-infectious doses of hepatitis B virus during preparation of a heat-inactivated hepatitis B vaccine.
    Lelie PN; Reesink HW; Niessen J; Brotman B; Prince AM
    J Med Virol; 1987 Nov; 23(3):289-95. PubMed ID: 2963091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo neutralization of hepatitis B virus infection by an anti-preS1 humanized antibody in chimpanzees.
    Hong HJ; Ryu CJ; Hur H; Kim S; Oh HK; Oh MS; Park SY
    Virology; 2004 Jan; 318(1):134-41. PubMed ID: 14972542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.